| What it does | Stock screener and research platform for value investors who pick their own stocks
| Stock ratings for US stocks based on published research signals
|
|---|
| Stage | Not given
| Startup
|
|---|
| Founded | Not given
| 2025
|
|---|
| Based in | US
| PL
|
|---|
| Pricing model | Freemium
| Freemium
|
|---|
| Pricing | Curious is free. Serious plan $29/month or $299/year. Professional plan $99/month or $999/year. Home Market Packs for markets outside the US: one market $15/month or $149/year; all regions $499/month or $4,999/year. New accounts start with 30 days of Professional free, no card required, with a 30-da
| Free plan with limited access to 200 largest stocks. Paid Tessera plan: $2 for first month, then $29/month, billed monthly. Cancel anytime. 30-day money-back guarantee.
|
|---|
| Key features | - Company research with figures compared against peers and historical filing data
- Portfolio tracking showing holdings as one business with size, risk, income and shared exposure
- Thesis writing and nightly re-testing of guardrails against filed accounts
- Weekly brief summarizing which guardrails passed and failed across all holdings
- Excel add-in to pull filed figures directly into spreadsheets with source citations
- Access to 54 markets outside the US with Home Market Packs
- Ranked investor discipline tests including Graham, Buffett, Greenblatt and Piotroski methodologies
| - Six published research signals averaged into stock ratings
- Free access to ratings on the 200 largest US stocks
- Company financial analysis and sector comparisons
- Stock screening on valuation, profitability, growth and momentum
- Rules-based paper portfolio tracking with simulated trading
- Custom paper portfolios with historical backtesting
- Analyst estimates and DCF valuation tools
- CSV export for custom analysis
- Rating changes tracked weekly by signal
|
|---|
| What makes it different | - All figures sourced to their origin: filed statements with formulas and filing dates, or market data with its date
- Nightly re-testing of your investment thesis against new filings, with alerts only when guardrails break
- No investment advice, buy/sell recommendations, or fair value targets; you make all decisions
- Focuses exclusively on long-term investors who research companies; explicitly excludes traders and model-portfolio followers
| - Connects stock screening with company research and paper portfolio tracking in one workspace
- Ratings based on six published academic research signals, not proprietary black boxes
- Free access to research on largest 200 stocks, no credit card required
- Educational research and ranking signals, explicitly not investment advice
- Affordable paid plan at $2 first month then $29/month with backtesting and full universe access
|
|---|
| Community votes | 0 | 0 |
|---|
| DR (Domain Rating by Ahrefs) | 16 ● no change since last check | 4 ● no change since last check |
|---|
| Trust Flow (Majestic) | 7 | 3 |
|---|
| Citation Flow (Majestic) | 29 | 19 |
|---|
| Referring domains (Majestic) | 99 | 9 |
|---|
ValueScreener
Tessera Alpha